| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | RCC1L DENND4B EIF2B3 FGD3 DOCK1 DOCK2 DOCK3 KALRN SH2D3A MADD | 8.35e-05 | 231 | 192 | 10 | GO:0005085 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TRAF3IP1 MYO5C SHROOM4 MAGI2 MRTFB KIF3B SYNE2 NAV3 DLG1 KIF5B MRTFA VIL1 FLNA FLNB CALD1 NEBL TOGARAM2 CLSTN1 OPA1 LRRC27 STAU2 PPP1R18 MACF1 PHACTR1 | 1.49e-04 | 1099 | 192 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | methyl-CpG binding | 2.13e-04 | 31 | 192 | 4 | GO:0008327 | |
| GeneOntologyMolecularFunction | actin binding | MYO5C SHROOM4 MRTFB SYNE2 MRTFA VIL1 FLNA FLNB CALD1 NEBL LRRC27 PPP1R18 MACF1 PHACTR1 | 2.31e-04 | 479 | 192 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 3.66e-04 | 15 | 192 | 3 | GO:1990247 | |
| Domain | DOCK_N | 9.73e-06 | 5 | 187 | 3 | PF16172 | |
| Domain | DOCK_N | 9.73e-06 | 5 | 187 | 3 | IPR032376 | |
| Domain | RPEL | 3.36e-05 | 7 | 187 | 3 | PS51073 | |
| Domain | RPEL | 3.36e-05 | 7 | 187 | 3 | SM00707 | |
| Domain | RPEL | 3.36e-05 | 7 | 187 | 3 | PF02755 | |
| Domain | RPEL_repeat | 3.36e-05 | 7 | 187 | 3 | IPR004018 | |
| Domain | - | 5.10e-05 | 21 | 187 | 4 | 1.10.720.30 | |
| Domain | SAP | 6.18e-05 | 22 | 187 | 4 | PF02037 | |
| Domain | SAP | 7.42e-05 | 23 | 187 | 4 | SM00513 | |
| Domain | ACTININ_2 | 7.42e-05 | 23 | 187 | 4 | PS00020 | |
| Domain | ACTININ_1 | 7.42e-05 | 23 | 187 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 7.42e-05 | 23 | 187 | 4 | IPR001589 | |
| Domain | SAP | 1.04e-04 | 25 | 187 | 4 | PS50800 | |
| Domain | SAP_dom | 1.04e-04 | 25 | 187 | 4 | IPR003034 | |
| Domain | DHR-1_domain | 1.54e-04 | 11 | 187 | 3 | IPR027007 | |
| Domain | DHR_2 | 1.54e-04 | 11 | 187 | 3 | PS51651 | |
| Domain | DHR_1 | 1.54e-04 | 11 | 187 | 3 | PS51650 | |
| Domain | DHR-2 | 1.54e-04 | 11 | 187 | 3 | PF06920 | |
| Domain | DOCK | 1.54e-04 | 11 | 187 | 3 | IPR026791 | |
| Domain | DOCK_C | 1.54e-04 | 11 | 187 | 3 | IPR010703 | |
| Domain | DOCK-C2 | 1.54e-04 | 11 | 187 | 3 | PF14429 | |
| Domain | DHR-2 | 1.54e-04 | 11 | 187 | 3 | IPR027357 | |
| Domain | HMGL-like | 2.97e-04 | 3 | 187 | 2 | PF00682 | |
| Domain | PYR_CT | 2.97e-04 | 3 | 187 | 2 | PS50991 | |
| Domain | PYR_CT | 2.97e-04 | 3 | 187 | 2 | IPR000891 | |
| Domain | SH3 | 3.36e-04 | 216 | 187 | 9 | PS50002 | |
| Domain | SH3_domain | 3.85e-04 | 220 | 187 | 9 | IPR001452 | |
| Domain | CH | 4.84e-04 | 65 | 187 | 5 | SM00033 | |
| Domain | PDZ | 5.51e-04 | 141 | 187 | 7 | PF00595 | |
| Domain | PID_Shc-like | 5.90e-04 | 4 | 187 | 2 | IPR006019 | |
| Domain | DNA_pol_B | 5.90e-04 | 4 | 187 | 2 | PF00136 | |
| Domain | DNA-dir_DNA_pol_B | 5.90e-04 | 4 | 187 | 2 | IPR006172 | |
| Domain | DNA-dir_DNA_pol_B_exonuc | 5.90e-04 | 4 | 187 | 2 | IPR006133 | |
| Domain | DNA-dir_DNA_pol_B_multi_dom | 5.90e-04 | 4 | 187 | 2 | IPR006134 | |
| Domain | DNA_pol_B_exo1 | 5.90e-04 | 4 | 187 | 2 | PF03104 | |
| Domain | POLBc | 5.90e-04 | 4 | 187 | 2 | SM00486 | |
| Domain | CH | 6.82e-04 | 70 | 187 | 5 | PF00307 | |
| Domain | - | 7.28e-04 | 71 | 187 | 5 | 1.10.418.10 | |
| Domain | PDZ | 7.35e-04 | 148 | 187 | 7 | SM00228 | |
| Domain | - | 7.96e-04 | 150 | 187 | 7 | 2.30.42.10 | |
| Domain | CH | 8.26e-04 | 73 | 187 | 5 | PS50021 | |
| Domain | PDZ | 8.28e-04 | 151 | 187 | 7 | PS50106 | |
| Domain | PDZ | 8.61e-04 | 152 | 187 | 7 | IPR001478 | |
| Domain | CH-domain | 9.34e-04 | 75 | 187 | 5 | IPR001715 | |
| Domain | DMAP_binding | 9.78e-04 | 5 | 187 | 2 | PF06464 | |
| Domain | VWFA | 1.40e-03 | 82 | 187 | 5 | PS50234 | |
| Domain | - | 1.46e-03 | 6 | 187 | 2 | 3.90.1290.10 | |
| Domain | DMAP1-bd | 1.46e-03 | 6 | 187 | 2 | IPR010506 | |
| Domain | DMAP_binding | 1.46e-03 | 6 | 187 | 2 | SM01137 | |
| Domain | Spectrin | 1.51e-03 | 23 | 187 | 3 | PF00435 | |
| Domain | GUANYLATE_KINASE_2 | 1.51e-03 | 23 | 187 | 3 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 1.51e-03 | 23 | 187 | 3 | PS00856 | |
| Domain | SH3 | 1.53e-03 | 216 | 187 | 8 | SM00326 | |
| Domain | VWA | 1.55e-03 | 84 | 187 | 5 | SM00327 | |
| Domain | Plectin | 2.03e-03 | 7 | 187 | 2 | PF00681 | |
| Domain | Plectin_repeat | 2.03e-03 | 7 | 187 | 2 | IPR001101 | |
| Domain | PLEC | 2.03e-03 | 7 | 187 | 2 | SM00250 | |
| Domain | Guanylate_kin | 2.17e-03 | 26 | 187 | 3 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 2.17e-03 | 26 | 187 | 3 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 2.17e-03 | 26 | 187 | 3 | IPR008144 | |
| Domain | GuKc | 2.17e-03 | 26 | 187 | 3 | SM00072 | |
| Pubmed | EPPK1 NOL6 PGAM1 WDR43 GMPS BPTF AHNAK SYNE2 KIF5B FH SF3B2 DNMT1 FLNA FLNB POLE POLR2A HUWE1 IGF2BP3 IGF2BP2 IGF2R ASNS EIF5B MACF1 HERC5 | 3.24e-13 | 653 | 193 | 24 | 22586326 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPPK1 HIVEP2 TDRD3 WIZ PER2 AHNAK EIF2B3 INTS11 NADK AP1G2 SIPA1L2 DOCK3 FLNA CDC42BPA KALRN LAT2 POLE POLR2A HECTD4 SHC1 HUWE1 REV3L WDR59 MADD HIVEP3 IGF2R PPP1R15B DIP2C PC TJP3 | 7.15e-13 | 1105 | 193 | 30 | 35748872 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ATP6V1A WDR43 GMPS TDRD3 MRTFB WIZ AHNAK KIF5B SIPA1L2 SF3B2 WDR62 DNMT1 UBFD1 FLNA CALD1 NEBL POLR2A KIAA1671 IGF2BP1 IGF2BP3 IGF2BP2 CSNK2B STAU2 EIF5B MACF1 PC HERC5 | 2.70e-12 | 934 | 193 | 27 | 33916271 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ATP6V1A CPNE8 EPPK1 NOL6 F5 WDR43 MYO5C BPTF AHNAK SYNE2 KIF5B SF3B2 FLNA FLNB CALD1 NSF POLR2A CAT HUWE1 KIAA1671 IGF2BP1 IGF2BP3 IGF2BP2 IGF2R CSNK2B EIF5B UHRF1 MACF1 | 3.82e-12 | 1024 | 193 | 28 | 24711643 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EPPK1 AKR1A1 SREK1 PGAM1 GMPS ESYT2 MRTFB AHNAK SYNE2 DLG1 DLST KIF5B FH SF3B2 DNMT1 FLNA FLNB CALD1 NSF SHC1 VPS26A HUWE1 OPA1 IGF2BP2 IGF2R CSNK2B ASNS STAU2 EIF5B PC | 1.34e-10 | 1367 | 193 | 30 | 32687490 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CDK8 BDP1 ATP6V1A HIVEP2 SLC22A23 CDK19 GMPS BPTF ESYT2 MRTFB DLG1 TET3 DOCK1 FLNB FYTTD1 CDC42BPA CALD1 ARHGAP10 SOBP PCDH11Y HECTD4 GPATCH2 HUWE1 DNAH1 KIAA1671 HIVEP3 CBFA2T2 LRRC27 DIP2C MACF1 | 1.01e-09 | 1489 | 193 | 30 | 28611215 |
| Pubmed | ATP6V1A HMGCL GMPS MAGI2 ESYT2 NAV3 DLG1 DLST KIF5B ALDH9A1 SIPA1L2 SVOP DOCK3 FLNA FLNB ASRGL1 CDC42BPA KALRN HUWE1 OPA1 MADD STAU2 MACF1 TMEM35A PC PHACTR1 | 1.15e-09 | 1139 | 193 | 26 | 36417873 | |
| Pubmed | HIVEP2 TRAF3IP1 DIS3L ENPP2 MAGI2 WIZ PIAS3 NAV3 DLG1 DLST TAF1 SF3B2 DNMT1 DOCK3 FLNB KALRN HECTD4 VPS26A HUWE1 REV3L WDR59 MADD SCG3 CSNK2B WIF1 MACF1 PC | 3.15e-09 | 1285 | 193 | 27 | 35914814 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DCAF1 PGM3 GMPS ESYT2 EIF2B3 TMEM131L DLG1 ALDH9A1 SIPA1L2 SF3B2 FLNA FLNB NSF ARHGAP10 POLE SHC1 VPS26A HUWE1 OPA1 IGF2BP1 IGF2BP2 ASNS ATP2A1 | 6.04e-09 | 974 | 193 | 23 | 28675297 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | ATP6V1A EPPK1 ACAT2 AKR1A1 PGAM1 GMPS COPS8 AHNAK EIF2B3 KIF5B ALDH9A1 SF3B2 FLNA FLNB CALD1 NSF HUWE1 IGF2BP1 IGF2BP3 IGF2BP2 CSNK2B ASNS STAU2 EIF5B MACF1 | 6.42e-09 | 1149 | 193 | 25 | 35446349 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ATP6V1A NOL6 SREK1 WDR43 GMPS ESYT2 RCC1L AHNAK EIF2B3 NFRKB FH SF3B2 DNMT1 FLNA NSF VPS26A HUWE1 OPA1 IGF2BP1 IGF2BP3 IGF2BP2 CELF1 CSNK2B STAU2 EIF5B PC | 2.27e-08 | 1318 | 193 | 26 | 30463901 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ATP6V1A EPPK1 WDR81 DAPK1 PGAM1 AHNAK MOV10L1 FH DOCK2 FLNA FLNB POLR2A HUWE1 DNAH1 HIVEP3 EIF5B MACF1 PC ATP2A1 HYDIN | 2.88e-08 | 807 | 193 | 20 | 30575818 |
| Pubmed | PGAM1 STAT2 TDRD3 COPS8 NFRKB TMEM131L DLG1 ALDH9A1 SF3B2 WDR62 DNMT1 NEBL POLR2A SHC4 HUWE1 WDR59 MADD IGF2R TMEM35A | 3.23e-08 | 733 | 193 | 19 | 34672954 | |
| Pubmed | NOL6 HMGCL SREK1 STOX1 PGAM1 CREBRF BPTF AHNAK SYNE2 DLG1 DLST KIF5B SIPA1L2 VIL1 FLNA FLNB CALD1 PCDHGB5 CAT SCG3 TNN DGKK PCDHGB4 EIF5B MACF1 POLQ ATP2A1 | 3.46e-08 | 1442 | 193 | 27 | 35575683 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF1 ACAT2 NOL6 GMPS AHNAK EIF2B3 INTS11 AP1G2 DLST KIF5B ALDH9A1 SF3B2 DNMT1 FLNA FLNB POLE POLR2A CAT VPS26A HUWE1 WDR59 IGF2BP2 CSNK2B ASNS EIF5B MACF1 | 3.82e-08 | 1353 | 193 | 26 | 29467282 |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | EPPK1 PGM3 GMPS DLST KIF5B FH SF3B2 NSF CAT HUWE1 IGF2BP1 IGF2BP3 IGF2BP2 CSNK2B ASNS EIF5B PC | 5.91e-08 | 607 | 193 | 17 | 39147351 |
| Pubmed | CDK8 DCAF1 DIS3L SREK1 BPTF WIZ INTS11 NFRKB SFXN2 TAF1 SIPA1L2 WDR62 TBX3 ARHGAP10 POLR2A GPATCH2 REV3L OPA1 KIAA1671 IGF2BP2 CSNK2B MACF1 MAP2K7 | 7.24e-08 | 1116 | 193 | 23 | 31753913 | |
| Pubmed | GMPS AHNAK DLST SF3B2 FLNA FLNB CDC42BPA IGF2BP1 IGF2BP3 MACF1 PC | 8.96e-08 | 234 | 193 | 11 | 36243803 | |
| Pubmed | GMPS TDRD3 ESYT2 WIZ AHNAK SYNE2 INTS11 LBH DLG1 DNMT1 CDC42BPA ARHGAP10 POLR2A SHC1 HUWE1 OPA1 MADD KIAA1671 IGF2BP2 IGF2R PPP1R18 PC | 1.06e-07 | 1049 | 193 | 22 | 27880917 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATP6V1A NOL6 HMGCL SREK1 PGAM1 WDR43 INTS11 DLST KIF5B FH SF3B2 DNMT1 FLNA FLNB NSF POLE POLR2A HUWE1 OPA1 IGF2BP1 IGF2R CSNK2B ASNS EIF5B UHRF1 PC | 1.06e-07 | 1425 | 193 | 26 | 30948266 |
| Pubmed | TRAF3IP1 WDR81 DAPK1 MAGI2 TDRD3 KIF3B WIZ SYNE2 DLG1 KIF5B DNMT1 KALRN EBF3 NSF HECTD4 HUWE1 OPA1 IGF2R P2RX7 MACF1 PHACTR1 | 1.10e-07 | 963 | 193 | 21 | 28671696 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | EPPK1 MAGI2 SYNE2 DLG1 TAF1 TBX3 FYTTD1 POLR2A HUWE1 OPA1 IGF2BP1 CSNK2B MACF1 | 1.22e-07 | 358 | 193 | 13 | 32460013 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | STAT2 ESYT2 MRTFB AHNAK DLG1 KIF5B UBFD1 FLNA FLNB CALD1 NEBL KIAA1671 ARHGDIB IGF2R PPP1R18 MACF1 | 1.27e-07 | 565 | 193 | 16 | 25468996 |
| Pubmed | CDK8 ATP6V1A GMPS DLG1 KIF5B FH SF3B2 FLNA TBX3 FYTTD1 CDC42BPA NEBL NSF POLR2A SHC1 HUWE1 OPA1 DNAH1 IGF2BP3 IGF2BP2 CSNK2B ASNS EIF5B TJP3 | 1.30e-07 | 1247 | 193 | 24 | 27684187 | |
| Pubmed | Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms. | 1.68e-07 | 3 | 193 | 3 | 17296566 | |
| Pubmed | Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. | 1.68e-07 | 3 | 193 | 3 | 29476152 | |
| Pubmed | Initiation of stress granule assembly by rapid clustering of IGF2BP proteins upon osmotic shock. | 1.68e-07 | 3 | 193 | 3 | 32668274 | |
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 20627640 | ||
| Pubmed | Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer. | 1.68e-07 | 3 | 193 | 3 | 16049158 | |
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 9891060 | ||
| Pubmed | VICKZ proteins: a multi-talented family of regulatory RNA-binding proteins. | 1.68e-07 | 3 | 193 | 3 | 15601260 | |
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 20080952 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | DCAF1 CPNE8 MYO5C AHNAK DNMT1 DOCK1 FLNA FLNB CDC42BPA EIF5B | 2.17e-07 | 202 | 193 | 10 | 33005030 |
| Pubmed | Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. | 3.65e-07 | 27 | 193 | 5 | 23144326 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | EPPK1 NOL6 HSP90AA5P WDR43 MYO5C AHNAK KIF5B SF3B2 FLNA FLNB CALD1 SHC4 CAT IGF2BP1 IGF2BP3 EIF5B UHRF1 PPP1R18 PC HERC5 | 3.85e-07 | 949 | 193 | 20 | 36574265 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EPPK1 BPTF AHNAK KIF5B TAF1 SF3B2 DNMT1 FLNA FLNB POLR2A HUWE1 ASNS | 3.95e-07 | 332 | 193 | 12 | 32786267 |
| Pubmed | BPTF MRTFB WIZ AHNAK NFRKB DLG1 KIF5B TAF1 DNMT1 FLNA CALD1 POLR2A HUWE1 KIAA1671 PC | 4.99e-07 | 549 | 193 | 15 | 38280479 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | ATP6V1A EPPK1 GMPS AHNAK SF3B2 FLNA FLNB HUWE1 OPA1 IGF2BP1 IGF2BP3 IGF2BP2 ASNS EIF5B | 5.21e-07 | 477 | 193 | 14 | 31300519 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | PGAM1 GMPS NADK KIF5B FLNA FLNB CAT VPS26A HUWE1 IGF2BP1 ASNS EIF5B | 5.76e-07 | 344 | 193 | 12 | 30333137 |
| Pubmed | H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein. | 6.70e-07 | 4 | 193 | 3 | 10875929 | |
| Pubmed | mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry. | 6.70e-07 | 4 | 193 | 3 | 21576258 | |
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 15225648 | ||
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 26160756 | ||
| Pubmed | IMP2 axonal localization, RNA interactome, and function in the development of axon trajectories. | 6.70e-07 | 4 | 193 | 3 | 27385015 | |
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 27184842 | ||
| Pubmed | ATP6V1A CPNE8 NOL6 PARD6G WDR43 RCC1L AHNAK INTS11 DLST KIF5B SF3B2 DNMT1 VIL1 FLNA FYTTD1 CDC42BPA GPATCH2 IGF2BP1 IGF2BP3 IGF2BP2 CSNK2B STAU2 UHRF1 PC | 7.14e-07 | 1371 | 193 | 24 | 36244648 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SREK1 BPTF WIZ INTS11 DLST SIPA1L2 SF3B2 FYTTD1 CDC42BPA KALRN EBF3 POLR2A HECTD4 OPA1 IGF2BP1 IGF2BP3 IGF2BP2 SCG3 STAU2 EIF5B MACF1 | 7.36e-07 | 1082 | 193 | 21 | 38697112 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | EPPK1 ACAT2 CDK19 SREK1 CREBRF MAGI2 EIF2B3 NADK PIP5K1B KIF5B SF3B2 VIL1 EBF3 NSF POLE POLR2A BCAS1 OPA1 IGF2BP1 IGF2BP3 IGF2BP2 CSNK2B POLQ | 8.40e-07 | 1284 | 193 | 23 | 17353931 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | GMPS AHNAK SYNE2 KIF5B FLNA FLNB CALD1 POLR2A IGF2BP1 IGF2BP3 CELF1 ASNS EIF5B MACF1 | 8.67e-07 | 498 | 193 | 14 | 36634849 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | DCAF1 HIVEP2 NOL6 GMPS COPS8 NFRKB DLG1 DLST KIF5B ALDH9A1 DNMT1 FLNA FLNB NSF CAT HUWE1 WDR59 IGF2R CELF1 CSNK2B | 9.37e-07 | 1005 | 193 | 20 | 19615732 |
| Pubmed | ATP6V1A F5 WDR43 AHNAK DLG1 DLST FLNA FLNB CALD1 NSF KIAA1671 CSNK2B EIF5B UHRF1 PPP1R18 MACF1 | 9.94e-07 | 660 | 193 | 16 | 32780723 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | EPPK1 SREK1 GMPS WIZ AHNAK SF3B2 DOCK1 DOCK2 FYTTD1 NSF POLE SHC1 HUWE1 MACF1 MAP2K7 | 1.03e-06 | 582 | 193 | 15 | 20467437 |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | DCAF1 NOL6 SREK1 PGM3 GMPS TDRD3 SFXN2 SF3B2 FYTTD1 POLR2A IGF2BP3 STAU2 | 1.04e-06 | 364 | 193 | 12 | 24778252 |
| Pubmed | CDK8 and CDK19 act redundantly to control the CFTR pathway in the intestinal epithelium. | 1.67e-06 | 5 | 193 | 3 | 36545778 | |
| Pubmed | ATP6V1A CPNE8 NOL6 PGM3 ESYT2 AHNAK SYNE2 EIF2B3 DLST FLNA FLNB CALD1 NSF HUWE1 KIAA1671 IGF2BP1 IGF2BP3 IGF2BP2 CSNK2B ASNS STAU2 EIF5B PPP1R18 HERC5 | 1.68e-06 | 1440 | 193 | 24 | 30833792 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NOL6 SREK1 WDR43 BPTF WIZ AHNAK NFRKB TAF1 SF3B2 DNMT1 FLNA CALD1 POLR2A IGF2BP1 CSNK2B STAU2 EIF5B PC ATP2A1 | 1.76e-06 | 954 | 193 | 19 | 36373674 |
| Pubmed | ATP6V1A GMPS COCH PPT2 COPS8 EIF2B3 TMEM131L TFB2M SF3B2 HUWE1 IGF2BP1 IGF2BP3 IGF2R ITPRIP MAP2K7 | 1.95e-06 | 613 | 193 | 15 | 22268729 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | EPPK1 NOL6 PGM3 INTS11 KIF5B ALDH9A1 DNMT1 POLE POLR2A HUWE1 IGF2BP1 IGF2BP3 IGF2BP2 ASNS STAU2 PC | 2.28e-06 | 704 | 193 | 16 | 29955894 |
| Pubmed | PGAM1 GMPS ESYT2 AHNAK DLG1 KIF5B SF3B2 DOCK1 FLNB CDC42BPA CALD1 NSF OPA1 IGF2R EIF5B MACF1 | 2.45e-06 | 708 | 193 | 16 | 39231216 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | NOL6 PGAM1 GMPS DLST SF3B2 FLNA FYTTD1 NSF POLR2A MADD IGF2BP1 IGF2BP3 IGF2BP2 CELF1 ASNS STAU2 | 2.73e-06 | 714 | 193 | 16 | 28302793 |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | NOL6 DAPK1 PGM3 GMPS INTS11 TFB2M ASRGL1 CALD1 POLE ACAD10 HUWE1 IGF2BP1 | 2.76e-06 | 400 | 193 | 12 | 35013556 |
| Pubmed | 2.80e-06 | 156 | 193 | 8 | 29961565 | ||
| Pubmed | WIZ DLST KIF5B FH SF3B2 FLNA FLNB CAT HUWE1 IGF2BP1 IGF2BP3 IGF2BP2 CSNK2B ASNS | 2.82e-06 | 551 | 193 | 14 | 34728620 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | F5 TDRD3 NFRKB NAV3 DNMT1 THSD7A KALRN POLR2A CAT ACAD10 MADD STAU2 EIF5B | 2.89e-06 | 475 | 193 | 13 | 31040226 |
| Pubmed | DCAF1 CPNE8 SREK1 ESYT2 COCH SYNE2 TMEM131L DLG1 DLST ALDH9A1 SIPA1L2 SF3B2 WDR62 DNMT1 CDC42BPA NSF POLE IGF2R PPP1R15B ASNS STAU2 EIF5B MACF1 HERC5 | 2.92e-06 | 1487 | 193 | 24 | 33957083 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | EPPK1 SREK1 TDRD3 RCC1L TFB2M SF3B2 FLNA FLNB FYTTD1 POLR2A IGF2BP1 IGF2BP3 IGF2BP2 CELF1 STAU2 EIF5B MACF1 | 3.02e-06 | 807 | 193 | 17 | 22681889 |
| Pubmed | DIS3L PARD6G DAPK1 SREK1 KIF3B SF3B2 FYTTD1 CALD1 POLR2A WDR59 IGF2BP1 IGF2BP3 IGF2BP2 CELF1 STAU2 EIF5B | 3.20e-06 | 723 | 193 | 16 | 34133714 | |
| Pubmed | DCAF1 CDK19 MAGI2 KIF3B PER2 DENND4B NAV3 SIPA1L2 TET3 OPA1 MADD MACF1 | 3.30e-06 | 407 | 193 | 12 | 12693553 | |
| Pubmed | 3.32e-06 | 6 | 193 | 3 | 33436560 | ||
| Pubmed | ATP6V1A TTR PGM3 MAGI2 DLG1 DLST FLNA ASRGL1 BCAS1 CLSTN1 MACF1 | 3.64e-06 | 341 | 193 | 11 | 29791485 | |
| Pubmed | CDK8 PGAM1 GMPS BPTF WIZ NFRKB KIF5B DNMT1 DOCK2 FLNA EBF3 TOGARAM2 ARHGDIB IGF2BP1 IGF2BP3 IGF2BP2 CELF1 ASNS EIF5B MAP2K7 | 3.82e-06 | 1103 | 193 | 20 | 34189442 | |
| Pubmed | MRTFB WIZ AHNAK TAF1 MRTFA WDR62 SFMBT1 FLNA FLNB HUWE1 KIAA1671 PC | 4.33e-06 | 418 | 193 | 12 | 34709266 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | ATP6V1A AKR1A1 SERPINA4 KIF3B WIZ COPS8 AHNAK ALDH9A1 VIL1 FLNA FLNB COL6A3 CDC42BPA NEBL KALRN HUWE1 ARHGDIB IGF2R CRB2 | 4.36e-06 | 1016 | 193 | 19 | 19056867 |
| Pubmed | ATP6V1A EPPK1 NOL6 GMPS WIZ SYNE2 TFB2M VSIG10L2 SF3B2 MRTFA FLNA NSF POLR2A VPS26A IGF2BP3 JRK | 5.44e-06 | 754 | 193 | 16 | 35906200 | |
| Pubmed | Dynamics of DNA hydroxymethylation and methylation during mouse embryonic and germline development. | 5.79e-06 | 7 | 193 | 3 | 36539615 | |
| Pubmed | DCAF1 BPTF AHNAK KIF5B SF3B2 FLNA FLNB CALD1 PPP1R18 MACF1 PC | 6.09e-06 | 360 | 193 | 11 | 33111431 | |
| Pubmed | 6.34e-06 | 47 | 193 | 5 | 32892421 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 6.56e-06 | 232 | 193 | 9 | 25515538 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ATP6V1A ACAT2 GMPS COPS8 AHNAK EIF2B3 NFRKB KIF5B FH ALDH9A1 UBFD1 FLNA FLNB CALD1 POLR2A SCLY VPS26A HUWE1 IGF2BP3 CSNK2B ASNS EIF5B MACF1 | 6.70e-06 | 1455 | 193 | 23 | 22863883 |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 7.27e-06 | 235 | 193 | 9 | 28378594 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 7.27e-06 | 235 | 193 | 9 | 30258100 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | GMPS BPTF TDRD3 WIZ TAF1 FYTTD1 POLR2A IGF2BP3 PPP1R18 PC MAP2K7 | 7.88e-06 | 370 | 193 | 11 | 22922362 |
| Pubmed | ESYT2 COCH SFXN2 TFB2M SIPA1L2 WDR62 NSF POLE HUWE1 WDR59 OPA1 KIAA1671 PC MAP2K7 | 8.32e-06 | 606 | 193 | 14 | 36538041 | |
| Pubmed | β-Actin mRNA interactome mapping by proximity biotinylation. | 8.95e-06 | 24 | 193 | 4 | 31189591 | |
| Pubmed | The Cdk8/19-cyclin C transcription regulator functions in genome replication through metazoan Sld7. | 9.23e-06 | 8 | 193 | 3 | 30695077 | |
| Pubmed | ADGRE2 KCNH1 NFRKB NADK TMEM131L DLG1 TFB2M MRTFA FLNA FLNB FYTTD1 HUWE1 MADD IGF2R CELF1 P2RX7 ITPRIP MACF1 PHACTR1 | 1.09e-05 | 1084 | 193 | 19 | 11544199 | |
| Pubmed | Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells. | 1.22e-05 | 137 | 193 | 7 | 37039823 | |
| Pubmed | TRAF3IP1 NFRKB KIF5B TAF1 SF3B2 DOCK1 POLR2A IGF2BP1 IGF2BP3 IGF2BP2 CSNK2B | 1.29e-05 | 390 | 193 | 11 | 17643375 | |
| Pubmed | SREK1 ESYT2 AHNAK DLG1 DLST KIF5B SF3B2 WDR62 FLNA CDC42BPA IGF2BP1 IGF2BP3 IGF2R CSNK2B ASNS EIF5B | 1.30e-05 | 809 | 193 | 16 | 32129710 | |
| Pubmed | METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression. | 1.38e-05 | 9 | 193 | 3 | 37340443 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.44e-05 | 256 | 193 | 9 | 33397691 | |
| Pubmed | ATP6V1A GMPS ESYT2 SF3B2 FLNA FLNB NSF POLR2A HUWE1 IGF2BP1 CSNK2B ASNS EIF5B MAP2K7 | 1.48e-05 | 638 | 193 | 14 | 33239621 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 1.55e-05 | 197 | 193 | 8 | 20811636 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | ATP6V1A ACAT2 AKR1A1 TTR ESYT2 NAV3 DLST ALDH9A1 SIPA1L2 CDC42BPA NSF CAT KIAA1671 STAU2 EIF5B | 1.62e-05 | 732 | 193 | 15 | 34732716 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | STOX1 GMPS TDRD3 WIZ AHNAK DENND4B VIL1 FLNB POLR2A HUWE1 REV3L KIAA1671 IGF2BP3 ASNS POTEA | 1.73e-05 | 736 | 193 | 15 | 29676528 |
| Pubmed | 1.97e-05 | 99 | 193 | 6 | 34161765 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | DIS3L WDR81 STAT2 WDR43 MRTFB EIF2B3 AP1G2 MRTFA POLR2A SHC1 GPATCH2 MADD IGF2BP1 PDE8B CSNK2B EIF5B MAP2K7 TJP3 | 2.16e-05 | 1038 | 193 | 18 | 26673895 |
| Pubmed | 2.37e-05 | 209 | 193 | 8 | 36779422 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NOL6 WDR43 BPTF TDRD3 DLST DNMT1 FYTTD1 POLE IGF2BP1 IGF2BP3 IGF2BP2 STAU2 UHRF1 MACF1 HERC5 | 2.46e-05 | 759 | 193 | 15 | 35915203 |
| Pubmed | 2.47e-05 | 103 | 193 | 6 | 10574462 | ||
| Interaction | SIRT7 interactions | DCAF1 EPPK1 NOL6 PGAM1 WDR43 GMPS BPTF AHNAK SYNE2 KIF5B FH SF3B2 DNMT1 FLNA FLNB POLE POLR2A HUWE1 IGF2BP3 IGF2BP2 IGF2R ASNS EIF5B MACF1 HERC5 | 4.12e-08 | 744 | 191 | 25 | int:SIRT7 |
| Interaction | TOP3B interactions | EPPK1 HIVEP2 DAZL TDRD3 WIZ PER2 AHNAK EIF2B3 INTS11 NADK AP1G2 DLST SIPA1L2 DOCK3 FLNA CDC42BPA KALRN LAT2 POLE POLR2A HECTD4 SHC1 HUWE1 REV3L WDR59 MADD HIVEP3 IGF2BP1 IGF2BP2 IGF2R CELF1 PPP1R15B DIP2C PC TJP3 | 3.63e-07 | 1470 | 191 | 35 | int:TOP3B |
| Interaction | NAA40 interactions | ATP6V1A WDR43 GMPS TDRD3 MRTFB WIZ AHNAK KIF5B SIPA1L2 SF3B2 WDR62 DNMT1 UBFD1 FLNA CALD1 NEBL POLR2A KIAA1671 IGF2BP1 IGF2BP3 IGF2BP2 CSNK2B STAU2 EIF5B MACF1 PC HERC5 | 5.90e-07 | 978 | 191 | 27 | int:NAA40 |
| Interaction | MKRN2 interactions | DAZL MAGI2 TDRD3 SYNE2 DLG1 TAF1 TBX3 FYTTD1 OPA1 IGF2BP1 IGF2BP3 IGF2BP2 CELF1 STAU2 MACF1 | 4.25e-06 | 385 | 191 | 15 | int:MKRN2 |
| Interaction | ECT2 interactions | EPPK1 NOL6 SREK1 HSP90AA5P WDR43 MYO5C ESYT2 AHNAK NAV3 ACCS SF3B2 FLNA FLNB WDR59 MADD KIAA1671 IGF2BP1 IGF2BP3 IGF2BP2 EIF5B PPP1R18 MACF1 ATP2A1 | 1.21e-05 | 887 | 191 | 23 | int:ECT2 |
| Interaction | OBSL1 interactions | EPPK1 NOL6 WDR43 AHNAK SYNE2 SIPA1L2 SF3B2 FLNA FLNB CALD1 POLR2A HUWE1 DNAH1 IGF2BP1 IGF2BP3 P2RX7 PDIK1L CSNK2B STAU2 EIF5B UHRF1 MACF1 POLQ | 1.58e-05 | 902 | 191 | 23 | int:OBSL1 |
| Interaction | CCDC8 interactions | CPNE8 EPPK1 F5 MYO5C AHNAK FLNA FLNB NSF POLR2A CAT HUWE1 KIAA1671 IGF2BP1 IGF2BP3 IGF2BP2 IGF2R STAU2 UHRF1 MACF1 | 1.62e-05 | 656 | 191 | 19 | int:CCDC8 |
| Interaction | LRRC31 interactions | DCAF1 CPNE8 MYO5C AHNAK DNMT1 DOCK1 FLNA FLNB CDC42BPA EIF5B | 2.70e-05 | 205 | 191 | 10 | int:LRRC31 |
| Interaction | SYNGAP1 interactions | PIAS3 SYNE2 DLG1 DLST SIPA1L2 DOCK1 DOCK3 ASRGL1 KALRN HUWE1 OPA1 STAU2 | 3.85e-05 | 307 | 191 | 12 | int:SYNGAP1 |
| Interaction | KIF23 interactions | EPPK1 NOL6 HSP90AA5P WDR43 MYO5C CLCN1 PER2 AHNAK ACCS SF3B2 FLNA FLNB GPATCH2 HUWE1 OPA1 IGF2BP1 IGF2BP3 IGF2BP2 ASNS STAU2 EIF5B UHRF1 MACF1 HERC5 | 4.43e-05 | 1031 | 191 | 24 | int:KIF23 |
| Interaction | SUMO2 interactions | EPPK1 PGAM1 BPTF PIAS3 AHNAK KIF5B TAF1 SF3B2 DNMT1 FLNA FLNB KALRN SOBP POLR2A HUWE1 CSNK2B ASNS | 5.02e-05 | 591 | 191 | 17 | int:SUMO2 |
| Interaction | STRAP interactions | DAZL TDRD3 KIF5B FLNA FLNB FYTTD1 HUWE1 IGF2BP1 IGF2BP2 CELF1 PC | 5.61e-05 | 270 | 191 | 11 | int:STRAP |
| Interaction | MIR29B2 interactions | 5.75e-05 | 71 | 191 | 6 | int:MIR29B2 | |
| Interaction | NR2C2 interactions | DCAF1 ATP6V1A NOL6 SREK1 WDR43 GMPS ESYT2 RCC1L AHNAK EIF2B3 NFRKB FH SF3B2 WDR62 DNMT1 FLNA LHX4 NSF VPS26A HUWE1 OPA1 IGF2BP1 IGF2BP3 IGF2BP2 CELF1 CSNK2B STAU2 EIF5B PC | 5.89e-05 | 1403 | 191 | 29 | int:NR2C2 |
| Interaction | MEX3A interactions | EPPK1 DAZL TDRD3 AHNAK DNMT1 FLNA FLNB HUWE1 CLSTN1 IGF2BP1 IGF2BP2 CELF1 MACF1 | 8.00e-05 | 384 | 191 | 13 | int:MEX3A |
| Interaction | GSK3B interactions | STAT2 GMPS TDRD3 ESYT2 COPS8 KIF5B SIPA1L2 MRTFA WDR62 DNMT1 FLNA ASRGL1 CAT KIAA1671 IGF2BP1 IGF2BP3 CSNK2B STAU2 UHRF1 MACF1 MAP2K7 | 8.01e-05 | 868 | 191 | 21 | int:GSK3B |
| Interaction | PLEKHF2 interactions | 8.59e-05 | 190 | 191 | 9 | int:PLEKHF2 | |
| Interaction | H2BC9 interactions | TRAF3IP1 ENPP2 DAPK1 PGM3 BPTF TDRD3 AHNAK SEPTIN1 DNMT1 POLR2A DNAH1 TNN DGKK PHACTR1 | 9.51e-05 | 446 | 191 | 14 | int:H2BC9 |
| Interaction | MIR92A1 interactions | 9.77e-05 | 78 | 191 | 6 | int:MIR92A1 | |
| Interaction | PFN1 interactions | PGAM1 STAT2 MYO5C TDRD3 ESYT2 KIF3B SYNE2 DLST SIPA1L2 SF3B2 MRTFA WDR62 DOCK1 KIAA1671 MACF1 | 1.08e-04 | 509 | 191 | 15 | int:PFN1 |
| Interaction | MIR143 interactions | 1.12e-04 | 80 | 191 | 6 | int:MIR143 | |
| Interaction | MIR10B interactions | 1.29e-04 | 82 | 191 | 6 | int:MIR10B | |
| Interaction | RBM47 interactions | 1.47e-04 | 204 | 191 | 9 | int:RBM47 | |
| Interaction | MIR199A1 interactions | 1.47e-04 | 84 | 191 | 6 | int:MIR199A1 | |
| Interaction | MIR7-2 interactions | 1.47e-04 | 84 | 191 | 6 | int:MIR7-2 | |
| Interaction | MIR107 interactions | 1.57e-04 | 85 | 191 | 6 | int:MIR107 | |
| Interaction | MIR18B interactions | 1.57e-04 | 85 | 191 | 6 | int:MIR18B | |
| Interaction | MIR17 interactions | 1.57e-04 | 85 | 191 | 6 | int:MIR17 | |
| Interaction | MIR9-1 interactions | 1.57e-04 | 85 | 191 | 6 | int:MIR9-1 | |
| Interaction | MIR20B interactions | 1.68e-04 | 86 | 191 | 6 | int:MIR20B | |
| Interaction | MIR138-2 interactions | 1.91e-04 | 88 | 191 | 6 | int:MIR138-2 | |
| Interaction | LSM14A interactions | 1.95e-04 | 260 | 191 | 10 | int:LSM14A | |
| Interaction | MIR29C interactions | 2.03e-04 | 89 | 191 | 6 | int:MIR29C | |
| Interaction | MIR221 interactions | 2.16e-04 | 90 | 191 | 6 | int:MIR221 | |
| Interaction | MIR92A2 interactions | 2.16e-04 | 90 | 191 | 6 | int:MIR92A2 | |
| Interaction | NRIP1 interactions | 2.23e-04 | 170 | 191 | 8 | int:NRIP1 | |
| Interaction | CEBPB interactions | CDK8 ATP6V1A PGAM1 GMPS BPTF AHNAK EIF2B3 DLST KIF5B FH SF3B2 DNMT1 DOCK2 FLNA FLNB FYTTD1 NSF POLR2A CAT OPA1 IGF2BP1 IGF2BP2 CELF1 CSNK2B ASNS STAU2 EIF5B UHRF1 | 2.31e-04 | 1443 | 191 | 28 | int:CEBPB |
| Interaction | DSCAM interactions | 2.32e-04 | 171 | 191 | 8 | int:DSCAM | |
| Interaction | MIR155 interactions | 2.43e-04 | 92 | 191 | 6 | int:MIR155 | |
| Interaction | MIR128-1 interactions | 2.43e-04 | 92 | 191 | 6 | int:MIR128-1 | |
| Interaction | KDM1A interactions | MRTFB WIZ AHNAK AP1G2 KIF5B TAF1 SF3B2 MRTFA WDR62 DNMT1 SFMBT1 FLNA FLNB POLR2A SHC1 HUWE1 KIAA1671 CSNK2B JRK UHRF1 PC | 2.44e-04 | 941 | 191 | 21 | int:KDM1A |
| Interaction | ACTB interactions | ATP6V1A TRAF3IP1 TTR MRTFB NFRKB SIPA1L2 MRTFA FLNA FLNB CALD1 NEBL POLR2A SHC1 KIAA1671 IGF2BP1 IGF2BP3 IGF2BP2 P2RX7 CSNK2B STAU2 PPP1R18 MACF1 HERC5 | 2.50e-04 | 1083 | 191 | 23 | int:ACTB |
| Interaction | MIR214 interactions | 2.58e-04 | 93 | 191 | 6 | int:MIR214 | |
| Interaction | MIR205 interactions | 2.58e-04 | 93 | 191 | 6 | int:MIR205 | |
| Interaction | HDAC4 interactions | TDRD3 NFRKB NAV3 NADK KIF5B DNMT1 TBX3 THSD7A KALRN POLR2A SHC1 CAT ACAD10 HUWE1 REV3L MADD STAU2 EIF5B | 2.64e-04 | 744 | 191 | 18 | int:HDAC4 |
| Interaction | EZR interactions | MYO5C TDRD3 PER2 AHNAK DLG1 FH CDC42BPA CALD1 NEBL SHC1 KIAA1671 ARHGDIB STAU2 PPP1R18 MACF1 | 2.65e-04 | 553 | 191 | 15 | int:EZR |
| Interaction | PINK1 interactions | ATP6V1A EPPK1 HSP90AA5P GMPS COPS8 AHNAK SF3B2 FLNA FLNB HUWE1 OPA1 IGF2BP1 IGF2BP3 IGF2BP2 ASNS EIF5B PC | 2.65e-04 | 679 | 191 | 17 | int:PINK1 |
| Interaction | MIR19B2 interactions | 2.73e-04 | 94 | 191 | 6 | int:MIR19B2 | |
| Interaction | MIRLET7F1 interactions | 2.73e-04 | 94 | 191 | 6 | int:MIRLET7F1 | |
| Interaction | CDK8 interactions | 2.77e-04 | 222 | 191 | 9 | int:CDK8 | |
| Interaction | BAP1 interactions | ATP6V1A EPPK1 ACAT2 AKR1A1 PGAM1 GMPS COPS8 AHNAK EIF2B3 KIF5B FH ALDH9A1 SF3B2 FLNA FLNB CALD1 NSF HUWE1 IGF2BP1 IGF2BP3 IGF2BP2 CSNK2B ASNS STAU2 EIF5B MACF1 | 2.93e-04 | 1314 | 191 | 26 | int:BAP1 |
| Interaction | MIR21 interactions | 3.24e-04 | 97 | 191 | 6 | int:MIR21 | |
| Interaction | MIR363 interactions | 3.24e-04 | 97 | 191 | 6 | int:MIR363 | |
| Interaction | MIR106B interactions | 3.42e-04 | 98 | 191 | 6 | int:MIR106B | |
| Interaction | YWHAE interactions | DCAF1 HIVEP2 ACAT2 PARD6G PER2 NADK DLST KIF5B FH SIPA1L2 SF3B2 WDR62 DNMT1 FLNA CDC42BPA CALD1 SH2D3A SHC1 HUWE1 KIAA1671 IGF2BP1 IGF2BP3 ASNS MACF1 MTBP | 3.54e-04 | 1256 | 191 | 25 | int:YWHAE |
| Cytoband | 11p11 | 1.74e-04 | 5 | 193 | 2 | 11p11 | |
| Cytoband | 2q37.3 | 3.22e-04 | 77 | 193 | 4 | 2q37.3 | |
| GeneFamily | PDZ domain containing | 6.59e-05 | 152 | 119 | 7 | 1220 | |
| GeneFamily | DNA polymerases | 4.47e-04 | 23 | 119 | 3 | 535 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 6.47e-04 | 26 | 119 | 3 | 904 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.17e-03 | 8 | 119 | 2 | 939 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.26e-03 | 181 | 119 | 6 | 694 | |
| GeneFamily | Zinc fingers CXXC-type | 2.72e-03 | 12 | 119 | 2 | 136 | |
| GeneFamily | RNA binding motif containing | 2.87e-03 | 213 | 119 | 6 | 725 | |
| GeneFamily | Aldo-keto reductases | 4.26e-03 | 15 | 119 | 2 | 399 | |
| GeneFamily | SH2 domain containing | 4.46e-03 | 101 | 119 | 4 | 741 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CDK8 HIVEP2 CDK19 DAPK1 WDR43 GMPS BPTF TDRD3 SYNE2 NAV3 TMEM131L DLG1 MRTFA DOCK1 SFMBT1 FLNB CDC42BPA REV3L OPA1 IGF2BP3 IGF2R STAU2 MACF1 | 7.85e-08 | 856 | 191 | 23 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | CPNE8 ENPP2 DAPK1 F5 TTR MAGI2 AHNAK ALDH9A1 SIPA1L2 THSD7A NEBL PDE8B PCDHGB4 CACNG4 AGBL2 HYDIN CRB2 | 1.16e-06 | 574 | 191 | 17 | M39056 |
| Coexpression | PGF_UP.V1_UP | 1.13e-05 | 190 | 191 | 9 | M2674 | |
| Coexpression | GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_UP | 1.71e-05 | 200 | 191 | 9 | M7648 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 2.70e-05 | 212 | 191 | 9 | M39221 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BDP1 ENPP2 SREK1 BPTF TDRD3 SYNE2 KIF5B ASRGL1 CDC42BPA CALD1 ARHGAP10 VPS26A REV3L OPA1 EIF5B POLQ | 2.71e-05 | 656 | 191 | 16 | M18979 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BDP1 HIVEP2 APOBR CREBRF BPTF ESYT2 AHNAK DENND4B SEPTIN1 LBH TMEM131L FGD3 DNMT1 DOCK2 FLNA FYTTD1 HECTD4 VPS26A HUWE1 REV3L HIVEP3 ARHGDIB CELF1 PPP1R15B PPP1R18 MACF1 | 3.34e-05 | 1492 | 191 | 26 | M40023 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | NOL6 APOBR PGAM1 STAT2 TMEM131L ACCS AP1G2 FGD3 DNMT1 DOCK2 TOGARAM2 CAT CLSTN1 WDR59 DNAH1 P2RX7 PLCH2 PPP1R18 ENG | 3.73e-05 | 905 | 191 | 19 | M40865 |
| Coexpression | SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP | 4.21e-05 | 27 | 191 | 4 | M14614 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | OPN3 CDK19 FH DNMT1 POLR2A SHC1 DCLRE1B OPA1 KMO CSNK2B PPP1R15B UHRF1 ITPRIP MTBP POLQ SLC16A10 | 7.39e-05 | 714 | 191 | 16 | M1744 |
| Coexpression | FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP | 7.98e-05 | 12 | 191 | 3 | M1338 | |
| Coexpression | GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP | 9.65e-05 | 195 | 191 | 8 | M8194 | |
| Coexpression | GSE3982_MAST_CELL_VS_MAC_DN | 9.65e-05 | 195 | 191 | 8 | M5431 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_UP | 1.11e-04 | 199 | 191 | 8 | M9414 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.11e-04 | 199 | 191 | 8 | M5893 | |
| Coexpression | GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP | 1.15e-04 | 200 | 191 | 8 | M9485 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_UP | 1.15e-04 | 200 | 191 | 8 | M8049 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_UP | 1.15e-04 | 200 | 191 | 8 | M3852 | |
| Coexpression | GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN | 1.15e-04 | 200 | 191 | 8 | M5068 | |
| Coexpression | GSE2585_THYMIC_DC_VS_MTEC_DN | 1.15e-04 | 200 | 191 | 8 | M6283 | |
| Coexpression | GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_DN | 1.15e-04 | 200 | 191 | 8 | M6358 | |
| Coexpression | GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_UP | 1.15e-04 | 200 | 191 | 8 | M4143 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.15e-04 | 200 | 191 | 8 | M9122 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 1.15e-04 | 200 | 191 | 8 | M9135 | |
| Coexpression | GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_UP | 1.20e-04 | 150 | 191 | 7 | M8796 | |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | 1.30e-04 | 152 | 191 | 7 | M39243 | |
| Coexpression | FOSTER_KDM1A_TARGETS_DN | 1.36e-04 | 205 | 191 | 8 | MM957 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 1.47e-04 | 155 | 191 | 7 | M39246 | |
| Coexpression | MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP | 1.50e-04 | 265 | 191 | 9 | M2255 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | CDK8 HIVEP2 DAPK1 WDR43 GMPS BPTF FLNB CDC42BPA REV3L OPA1 IGF2BP3 STAU2 | 1.70e-04 | 466 | 191 | 12 | M13522 |
| Coexpression | FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP | 1.99e-04 | 16 | 191 | 3 | MM559 | |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL | 2.08e-04 | 164 | 191 | 7 | M41676 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | CPNE8 DAPK1 MAGI2 TDRD3 MRTFB COPS8 SYNE2 LBH FLNA COL6A3 CALD1 NEBL KALRN REV3L ARHGDIB IGF2BP1 IGF2BP3 IGF2BP2 IGF2R ASNS UHRF1 | 1.60e-05 | 827 | 189 | 21 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | CPNE8 PARD6G DAPK1 MAGI2 TDRD3 MRTFB COPS8 LBH FLNA TBX3 CALD1 KALRN SOBP ARHGDIB IGF2BP1 IGF2BP3 IGF2BP2 IGF2R ASNS UHRF1 TMEM35A | 1.72e-05 | 831 | 189 | 21 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | F5 DLG1 PIP5K1B VIL1 FLNB TBX3 SOBP WDR59 IGF2BP1 IGF2BP3 IGF2BP2 CBFA2T2 | 5.50e-11 | 193 | 193 | 12 | 503a979328c68b096680b71359a26f02fafdff35 |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | CPNE8 ENPP2 MRTFB SYNE2 SIPA1L2 FLNB ASRGL1 THSD7A NEBL KIAA1671 ENG | 6.40e-10 | 187 | 193 | 11 | 40ffc06a3e3251d9b12da390210d3e045af7537a |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SHROOM4 MRTFB SIPA1L2 DOCK1 FLNB THSD7A KIAA1671 IGF2BP2 MACF1 ENG PHACTR1 | 9.45e-10 | 194 | 193 | 11 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | SLC22A23 KLRG2 DAPK1 MAGI2 NEBL ARHGAP10 BCAS1 SLIT3 CACNG4 HYDIN | 5.77e-09 | 177 | 193 | 10 | da8802a6351d3e510822f82e2fde8a4314a2216e |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | CPNE8 SHROOM4 MAGI2 AHNAK SYNE2 DOCK1 CDC42BPA CALD1 NEBL SOBP | 1.85e-08 | 200 | 193 | 10 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | CPNE8 SHROOM4 MAGI2 AHNAK SYNE2 DOCK1 CDC42BPA CALD1 NEBL SOBP | 1.85e-08 | 200 | 193 | 10 | 68fce28690246895fd33354b30960ebcc31aa4cc |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | CPNE8 SHROOM4 MAGI2 AHNAK SYNE2 DOCK1 CDC42BPA CALD1 NEBL SOBP | 1.85e-08 | 200 | 193 | 10 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | CPNE8 SHROOM4 MAGI2 AHNAK SYNE2 DOCK1 CDC42BPA CALD1 NEBL SOBP | 1.85e-08 | 200 | 193 | 10 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | CPNE8 SHROOM4 MAGI2 AHNAK SYNE2 DOCK1 CDC42BPA CALD1 NEBL SOBP | 1.85e-08 | 200 | 193 | 10 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | CPNE8 SHROOM4 MAGI2 AHNAK SYNE2 DOCK1 CDC42BPA CALD1 NEBL SOBP | 1.85e-08 | 200 | 193 | 10 | 7136936d05ab344a560cf159684c881063b5430d |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-07 | 181 | 193 | 9 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-07 | 181 | 193 | 9 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | SLC22A23 BPTF DLG1 PIP5K1B SOBP HECTD4 IGF2BP1 IGF2BP2 CBFA2T2 | 1.28e-07 | 186 | 193 | 9 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | SLC22A23 BPTF DLG1 PIP5K1B SOBP HECTD4 IGF2BP1 IGF2BP2 CBFA2T2 | 1.28e-07 | 186 | 193 | 9 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-07 | 192 | 193 | 9 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.68e-07 | 192 | 193 | 9 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | SREK1 ESYT2 AHNAK SYNE2 TMEM131L COL6A3 POLR2A PPP1R15B MACF1 | 1.68e-07 | 192 | 193 | 9 | 47646d7e4990be85072987f92bf18d52f8da752e |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ENPP2 SHROOM4 MRTFB SIPA1L2 FLNB THSD7A KIAA1671 ENG PHACTR1 | 1.75e-07 | 193 | 193 | 9 | e09387af84d2a0a526e54d4793e6e06c6739db53 |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ENPP2 SHROOM4 MRTFB FLNB THSD7A KIAA1671 IGF2BP2 ENG PHACTR1 | 1.75e-07 | 193 | 193 | 9 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.98e-07 | 175 | 193 | 8 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.98e-07 | 175 | 193 | 8 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-06 | 176 | 193 | 8 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-06 | 176 | 193 | 8 | 1dd54bfaa58541de51e5a8328651d390833bd480 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.18e-06 | 179 | 193 | 8 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-06 | 181 | 193 | 8 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-06 | 184 | 193 | 8 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 184 | 193 | 8 | 1c857126c0ea0671f0d60b048efca288d348d653 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.64e-06 | 187 | 193 | 8 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-06 | 190 | 193 | 8 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-06 | 190 | 193 | 8 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-06 | 190 | 193 | 8 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-06 | 191 | 193 | 8 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-06 | 191 | 193 | 8 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-06 | 193 | 193 | 8 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-06 | 193 | 193 | 8 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.08e-06 | 193 | 193 | 8 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.16e-06 | 194 | 193 | 8 | f2f7b9aad7588c8020a4850ff9333e1db8eafac7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 194 | 193 | 8 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 2.24e-06 | 195 | 193 | 8 | 120296531bbc8080dcabacbd64733cc1dc34603a | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|IPF / Disease state, Lineage and Cell class | 2.24e-06 | 195 | 193 | 8 | 2c3ad3cb79f11119ac69c413a938d21199145040 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 195 | 193 | 8 | 58b769da05a8f6b05aeb08d4f8b112941087ad00 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 195 | 193 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.24e-06 | 195 | 193 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.24e-06 | 195 | 193 | 8 | 023e3c97dd3696d74f002ff8da0c04d876c82aef | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 195 | 193 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.42e-06 | 197 | 193 | 8 | 1a137af40697137bb9d2b5caf2b1ffda55f04461 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.42e-06 | 197 | 193 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.42e-06 | 197 | 193 | 8 | f969685dee212f33a6f09e54c0cd1fd24ffef546 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-midbrain/hindbrain_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 2.42e-06 | 197 | 193 | 8 | c7078f6fcf27319ba8c5ebe700bcae7f1e7e39c1 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.42e-06 | 197 | 193 | 8 | 96d63a8d00583e2aa0a38412e2ae27e23f399493 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 2.51e-06 | 198 | 193 | 8 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | PSB-critical-LOC-Myeloid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.51e-06 | 198 | 193 | 8 | 437e2f84b64d99928aedbab7366ff0ec91e74038 | |
| ToppCell | E18.5-Mesenchymal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.51e-06 | 198 | 193 | 8 | a16aa41eab2e297e56de43c22c355df0f79315da | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 2.61e-06 | 199 | 193 | 8 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.61e-06 | 199 | 193 | 8 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.71e-06 | 200 | 193 | 8 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.71e-06 | 200 | 193 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.71e-06 | 200 | 193 | 8 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-BMP_responsible_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.71e-06 | 200 | 193 | 8 | 5fb90118d3abc28d72bc483e68317255090a04c7 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.71e-06 | 200 | 193 | 8 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 2.71e-06 | 200 | 193 | 8 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.71e-06 | 200 | 193 | 8 | 177f9ad8dd8635394c575a2b30140184df0bd51e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.71e-06 | 200 | 193 | 8 | 13ec8afea86e4a10599c924871ba4e325b0a8013 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-06 | 165 | 193 | 7 | ab6ed7e30096c418e7be2d5eec33feeddd1387d9 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 7.86e-06 | 165 | 193 | 7 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.55e-06 | 170 | 193 | 7 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.55e-06 | 170 | 193 | 7 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.55e-06 | 170 | 193 | 7 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 177 | 193 | 7 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-05 | 178 | 193 | 7 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.34e-05 | 179 | 193 | 7 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.34e-05 | 179 | 193 | 7 | b559f5a72cc9e3e35d05cb539b5c2e006e56e652 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-05 | 181 | 193 | 7 | b244ecaa442bbef51289d8ec574ef08fa9e96318 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-05 | 181 | 193 | 7 | dd79de8098edb385a0f85d0e9621503cdf76ec43 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-05 | 181 | 193 | 7 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-05 | 182 | 193 | 7 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-05 | 182 | 193 | 7 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 1.54e-05 | 183 | 193 | 7 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 183 | 193 | 7 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 1.54e-05 | 183 | 193 | 7 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.60e-05 | 184 | 193 | 7 | 087666ba949b129c53d7ace40f9e543e3875a7de | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.65e-05 | 185 | 193 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 185 | 193 | 7 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 185 | 193 | 7 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 185 | 193 | 7 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 185 | 193 | 7 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 185 | 193 | 7 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.71e-05 | 186 | 193 | 7 | f73cb91e74a806858650ae97f543fc779ba4cff8 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.71e-05 | 186 | 193 | 7 | 8694ca16c9780729f4fba67ba20e35745f1eb4e9 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-05 | 186 | 193 | 7 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.77e-05 | 187 | 193 | 7 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 187 | 193 | 7 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.77e-05 | 187 | 193 | 7 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 188 | 193 | 7 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 188 | 193 | 7 | b483b4629695764568bcbd1d527d614824147783 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 188 | 193 | 7 | c1f64311ff05093b2f4f672e33f5f75e3bc8a8db | |
| ToppCell | Control-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 1.90e-05 | 189 | 193 | 7 | c76d8af2e0aa4a83ee0c3439c894566fbf117dd3 | |
| ToppCell | MS-Treg-CD4_Treg|MS / Condition, Cell_class and T cell subcluster | 1.90e-05 | 189 | 193 | 7 | b1310eed6113b3536868340a5b2b2587ad377fa9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-05 | 189 | 193 | 7 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.90e-05 | 189 | 193 | 7 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| Disease | acquired metabolic disease (implicated_via_orthology) | 1.05e-06 | 4 | 190 | 3 | DOID:0060158 (implicated_via_orthology) | |
| Disease | Intellectual Disability | CDK8 HIVEP2 HMGCL PGM3 SHROOM4 BPTF TAF1 TFB2M TET3 WDR62 NSF MACF1 PHACTR1 | 7.31e-06 | 447 | 190 | 13 | C3714756 |
| Disease | response to anticonvulsant | 1.89e-05 | 85 | 190 | 6 | GO_0036277 | |
| Disease | collagen alpha-3(VI) chain measurement | 4.12e-05 | 2 | 190 | 2 | EFO_0802421 | |
| Disease | developmental and epileptic encephalopathy 87 (implicated_via_orthology) | 4.12e-05 | 2 | 190 | 2 | DOID:0112221 (implicated_via_orthology) | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 7.31e-05 | 108 | 190 | 6 | DOID:684 (biomarker_via_orthology) | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 1.23e-04 | 3 | 190 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 1.23e-04 | 3 | 190 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | nervousness | 1.38e-04 | 16 | 190 | 3 | NCIT_C74532 | |
| Disease | Liver Cirrhosis, Experimental | ENPP2 SLC22A23 SERPINA4 AHNAK LBH FLNA NAT8 KMO ARHGDIB IGF2BP3 IGF2R ASNS STAU2 PPP1R18 PC | 1.59e-04 | 774 | 190 | 15 | C0023893 |
| Disease | Global developmental delay | 2.29e-04 | 133 | 190 | 6 | C0557874 | |
| Disease | aortic measurement | 2.35e-04 | 251 | 190 | 8 | EFO_0020865 | |
| Disease | chronic obstructive pulmonary disease, interleukin-8 measurement | 2.45e-04 | 4 | 190 | 2 | EFO_0000341, EFO_0004811 | |
| Disease | response to carbamazepine | 2.45e-04 | 4 | 190 | 2 | EFO_0008484 | |
| Disease | ascending aortic diameter | 3.03e-04 | 140 | 190 | 6 | EFO_0021787 | |
| Disease | treatment resistant depression, response to antidepressant | 3.21e-04 | 21 | 190 | 3 | EFO_0009854, GO_0036276 | |
| Disease | serum metabolite measurement | MAGI2 SYNE2 DNMT1 ASRGL1 CDC42BPA NAT8 CAT BCAS1 REV3L SLCO6A1 KMO IGF2R CELF1 DIP2C SLC16A10 PHACTR1 | 4.33e-04 | 945 | 190 | 16 | EFO_0005653 |
| Disease | Seizures | 5.53e-04 | 218 | 190 | 7 | C0036572 | |
| Disease | hemoglobin A1 measurement | DCAF1 SLC22A23 MYO5C SYNE2 NSF MADD HIVEP3 IGF2BP3 IGF2BP2 CBFA2T2 MACF1 | 5.89e-04 | 520 | 190 | 11 | EFO_0007629 |
| Disease | chronic obstructive pulmonary disease, CC16 measurement | 6.08e-04 | 6 | 190 | 2 | EFO_0000341, EFO_0005080 | |
| Disease | Pituitary Gland Adenoma | 6.08e-04 | 6 | 190 | 2 | EFO_1000478 | |
| Disease | uric acid measurement | F5 SFXN2 PIP5K1B SFMBT1 CDC42BPA HECTD4 GPATCH2 ACAD10 BCAS1 IGF2BP2 DIP2C SLC16A10 | 6.34e-04 | 610 | 190 | 12 | EFO_0004761 |
| Disease | circadian rhythm | 6.78e-04 | 163 | 190 | 6 | EFO_0004354 | |
| Disease | creatinine measurement | AKR1A1 TTR TMEM131L DLG1 PIP5K1B FH MRTFA SFMBT1 VIL1 SCLY ACAD10 BCAS1 IGF2BP3 IGF2R PCDHGB4 DIP2C | 7.53e-04 | 995 | 190 | 16 | EFO_0004518 |
| Disease | chronic kidney disease | 8.60e-04 | 235 | 190 | 7 | EFO_0003884 | |
| Disease | mean platelet volume | HIVEP2 DIS3L SLC22A23 APOBR ESYT2 COCH SYNE2 TMEM131L MRTFA FGD3 PCDHGB5 KALRN POLR2A BCAS1 PCDHGB4 ITPRIP | 9.76e-04 | 1020 | 190 | 16 | EFO_0004584 |
| Disease | schizophrenia (implicated_via_orthology) | 9.83e-04 | 68 | 190 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | mental or behavioural disorder | 1.10e-03 | 179 | 190 | 6 | EFO_0000677 | |
| Disease | AUTISM, SUSCEPTIBILITY TO, 15 | 1.13e-03 | 8 | 190 | 2 | C2677504 | |
| Disease | Congenital Hydrocephalus | 1.13e-03 | 8 | 190 | 2 | C0020256 | |
| Disease | heart failure | 1.30e-03 | 185 | 190 | 6 | EFO_0003144 | |
| Disease | smoking status measurement | CPNE8 NOL6 PGPEP1 MAGI2 BPTF RNF150 TET3 CDC42BPA NSF HECTD4 REV3L UHRF1 ITPRIP AGBL2 KCNAB3 SLC16A10 PHACTR1 | 1.42e-03 | 1160 | 190 | 17 | EFO_0006527 |
| Disease | Williams-Beuren syndrome (is_implicated_in) | 1.44e-03 | 9 | 190 | 2 | DOID:1928 (is_implicated_in) | |
| Disease | PR interval | TTR CREBRF MAGI2 SYNE2 DLG1 SIPA1L2 KALRN HIVEP3 IGF2BP2 MACF1 | 1.46e-03 | 495 | 190 | 10 | EFO_0004462 |
| Disease | open-angle glaucoma | 1.53e-03 | 191 | 190 | 6 | EFO_0004190 | |
| Disease | eosinophil count | HIVEP2 STOX1 BPTF KIF3B LBH AP1G2 DLST TET3 DOCK3 FLNA HECTD4 SHC1 ACAD10 CLSTN1 WDR59 HIVEP3 IGF2BP1 PDE8B PPP1R18 POTEA | 1.55e-03 | 1488 | 190 | 20 | EFO_0004842 |
| Disease | pulse pressure measurement | ENPP2 AKR1A1 COPS8 INTS11 NADK KIF5B DNMT1 FLNB COL6A3 NEBL ACAD10 MADD HIVEP3 CELF1 SLIT3 UHRF1 AGBL2 HYDIN PHACTR1 | 1.70e-03 | 1392 | 190 | 19 | EFO_0005763 |
| Disease | osteonecrosis (is_implicated_in) | 1.79e-03 | 10 | 190 | 2 | DOID:10159 (is_implicated_in) | |
| Disease | chronotype measurement | CPNE8 TRAF3IP1 PGPEP1 MAGI2 PER2 NAV3 DOCK1 DOCK3 MADD DNAH1 PDE8B DIP2C PC PHACTR1 | 1.81e-03 | 882 | 190 | 14 | EFO_0008328 |
| Disease | kynurenine measurement | 2.03e-03 | 39 | 190 | 3 | EFO_0008529 | |
| Disease | Umbilical hernia | 2.18e-03 | 11 | 190 | 2 | HP_0001537 | |
| Disease | sexual dimorphism measurement | EPPK1 HIVEP2 PGPEP1 BPTF DOCK3 VIL1 CDC42BPA POLR2A MADD IGF2BP3 IGF2BP2 CELF1 CBFA2T2 SLIT3 MACF1 PC | 2.23e-03 | 1106 | 190 | 16 | EFO_0021796 |
| Disease | feeling nervous measurement | 2.44e-03 | 87 | 190 | 4 | EFO_0009597 | |
| Disease | serum gamma-glutamyl transferase measurement | PGPEP1 BPTF AHNAK SIPA1L2 DNMT1 CDC42BPA CALD1 KALRN ARHGAP10 HECTD4 SLCO1B7 CELF1 P2RX7 TJP3 | 2.50e-03 | 914 | 190 | 14 | EFO_0004532 |
| Disease | depressive symptom measurement, response to antidepressant | 2.55e-03 | 88 | 190 | 4 | EFO_0007006, GO_0036276 | |
| Disease | motor neuron disease (implicated_via_orthology) | 2.61e-03 | 12 | 190 | 2 | DOID:231 (implicated_via_orthology) | |
| Disease | blood urea nitrogen measurement | DAPK1 PIP5K1B VIL1 CDC42BPA GPATCH2 ACAD10 BCAS1 JRK PCDHGB4 | 2.76e-03 | 452 | 190 | 9 | EFO_0004741 |
| Disease | schizophrenia (is_marker_for) | 2.87e-03 | 44 | 190 | 3 | DOID:5419 (is_marker_for) | |
| Disease | atrial fibrillation | 2.91e-03 | 371 | 190 | 8 | EFO_0000275 | |
| Disease | gait measurement | 2.93e-03 | 150 | 190 | 5 | EFO_0007680 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 3.07e-03 | 13 | 190 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 3.49e-03 | 96 | 190 | 4 | C1319315 | |
| Disease | metabolite measurement | 3.56e-03 | 560 | 190 | 10 | EFO_0004725 | |
| Disease | myopathy (implicated_via_orthology) | 3.67e-03 | 48 | 190 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Generalized hypotonia | 4.10e-03 | 15 | 190 | 2 | C1858120 | |
| Disease | Hepatitis | 4.10e-03 | 15 | 190 | 2 | C0019158 | |
| Disease | risk-taking behaviour | CDK19 MAGI2 BPTF PPT2 TET3 BCAS1 REV3L HIVEP3 ASNS PC ATP2A1 KCNAB3 | 4.12e-03 | 764 | 190 | 12 | EFO_0008579 |
| Disease | Malignant neoplasm of breast | CLCN1 PER2 KCNH1 SYNE2 ACCS DNMT1 FLNA FLNB TBX3 KALRN SH2D3A CAT DIP2C MACF1 MAP2K7 | 4.20e-03 | 1074 | 190 | 15 | C0006142 |
| Disease | IGF-1 measurement | 4.55e-03 | 488 | 190 | 9 | EFO_0004627 | |
| Disease | proliferative diabetic retinopathy (is_marker_for) | 4.66e-03 | 16 | 190 | 2 | DOID:13207 (is_marker_for) | |
| Disease | Blood Coagulation Disorders | 4.66e-03 | 16 | 190 | 2 | C0005779 | |
| Disease | cystatin C measurement | 4.70e-03 | 402 | 190 | 8 | EFO_0004617 | |
| Disease | lifestyle measurement, depressive symptom measurement | 4.80e-03 | 105 | 190 | 4 | EFO_0007006, EFO_0010724 | |
| Disease | response to radiation, Urinary retention | 5.26e-03 | 17 | 190 | 2 | GO_0009314, HP_0000016 | |
| Disease | Adenomatous Polyposis Coli | 5.26e-03 | 17 | 190 | 2 | C0032580 | |
| Disease | forced expiratory volume | ENPP2 KIF3B AHNAK THSD7A IGF2BP3 IGF2BP2 CELF1 PDE8B PDIK1L UHRF1 PC HERC5 | 5.29e-03 | 789 | 190 | 12 | EFO_0004314 |
| Disease | Antithrombotic agent use measurement | 5.39e-03 | 55 | 190 | 3 | EFO_0009925 | |
| Disease | hippocampal atrophy | 5.67e-03 | 56 | 190 | 3 | EFO_0005039 | |
| Disease | triglycerides in LDL measurement | 5.67e-03 | 56 | 190 | 3 | EFO_0022320 | |
| Disease | bipolar disorder, sex interaction measurement | 5.90e-03 | 18 | 190 | 2 | EFO_0008343, MONDO_0004985 | |
| Disease | Feeding difficulties | 5.90e-03 | 18 | 190 | 2 | C0232466 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MLIPGPSLQIVKSEE | 591 | Q68DN1 | |
| AVVDPLFGMQPIRVK | 51 | P08243 | |
| RVILEPLIGDMPLVG | 301 | A0FGR8 | |
| EPGLTKGMLEVFVAP | 766 | P53355 | |
| PQENGLEEVKPLGEM | 1046 | A6H8Y1 | |
| NGVKLVDPLGEMLAP | 71 | O95394 | |
| KIGDPLLEDTRMGPL | 316 | P49189 | |
| VLPAGRVIGEPTSLM | 401 | P51689 | |
| DLKPANILVMGEGPE | 151 | Q9BWU1 | |
| PGIEASPDKMLQGRL | 341 | P04040 | |
| TVTNPEPMGKQGRVL | 1526 | P26358 | |
| DQKLPELRGVGDPAM | 41 | Q96QU6 | |
| SIPGMGKLLAEAPLV | 406 | Q9UHX3 | |
| AAAMGVPEIPGEKLV | 126 | Q7L266 | |
| PDLDAIKMFVGQVPR | 11 | Q92879 | |
| PRDERGPNMGQKLEI | 581 | Q8IUR6 | |
| PVIILGPMKDRINDD | 716 | Q12959 | |
| ESFIRMGIQPPKGVL | 651 | Q8NB90 | |
| ILEKMPLVERDGPQA | 581 | O75843 | |
| HVRVPKENMVLGPGR | 891 | Q6JQN1 | |
| MQVPDVDIRGPKVDI | 1096 | Q09666 | |
| MPSLKGEGPEVDVNL | 1136 | Q09666 | |
| VDLPKGDINIEGPSM | 3496 | Q09666 | |
| MVLQPEEPKISLSGV | 646 | O94985 | |
| KAIIRTPVMVQPGAP | 2201 | Q12830 | |
| KTREEIGLGSPLVPM | 446 | Q9H816 | |
| KLPDTPQGLLGEARM | 291 | P17813 | |
| LTFVGVVGMLDPPRK | 591 | O14983 | |
| VVGMLDPPRKEVTGS | 596 | O14983 | |
| GKGPNLVESAVPEMI | 366 | Q96I51 | |
| NRKVPEAMGLPEAVL | 481 | Q8IWB1 | |
| RIPEEMPKGSVVGNL | 36 | Q9UN71 | |
| DPEGMGIIPRIVQDI | 101 | P33176 | |
| IIPRPEGNAQLDKMG | 381 | A1A4S6 | |
| GVQKLLEIPRPSMAA | 396 | Q9Y4B6 | |
| QTPLLKGQVEMDVPR | 626 | Q5KSL6 | |
| VMVSGEPLLAKPARI | 81 | Q8TDR0 | |
| GRGDPKAMAQLRVPQ | 1076 | Q8WXG6 | |
| LSRKQMTEPEPGGLV | 391 | Q9BXT6 | |
| VLAGDPMQLGPVIKS | 911 | Q9BXT6 | |
| DEPGQPILIGAVIAM | 796 | Q86UL8 | |
| EKGPPANIREGLSIM | 1411 | Q9BY89 | |
| ATIRIVQGLGVMPPK | 1086 | Q6P4R8 | |
| LKPDLSPEVRGQVQM | 256 | Q6PRD1 | |
| MPEIRVTPLGAGQDV | 1 | Q5TA45 | |
| AGARLEMDSVLKVPP | 1266 | Q5IJ48 | |
| VRMVIITGPPEAQFK | 451 | Q9NZI8 | |
| QPMEEIGLSPRKDGL | 26 | Q53QV2 | |
| PSGRVTEAEIVPMGK | 2136 | O75369 | |
| DINAAITKEMPPLRG | 306 | Q58FG0 | |
| RVPAMPGSPVEVKIQ | 26 | O43439 | |
| PAGVELKIMLSPEAR | 361 | O95544 | |
| SGKELGMLVEPPDAR | 61 | O15055 | |
| QDTLRGMQLEKRPPG | 466 | A0A0J9YXQ4 | |
| RSEGVPVSGPMLIEK | 101 | O75564 | |
| QGPIPERILGKMTVA | 211 | O14733 | |
| MEQPRKAVVVTGFGP | 1 | Q9NXJ5 | |
| QTDEEKRQGLPVVMP | 806 | O95263 | |
| IITENPDTMGGIPAK | 321 | O14986 | |
| MPVLGVASKLRQPAV | 1 | Q8IVL0 | |
| MTSGVEEIPPGILNK | 1311 | O60229 | |
| TREQLVDQGIMPPLK | 51 | Q9ULH7 | |
| NEKIAQRPGPMELVE | 131 | Q9ULH7 | |
| REPQILKEVQSPEGM | 801 | Q9H6R4 | |
| KQLMDPRGPGDIRTV | 986 | Q9H6R4 | |
| PAGEVISDPKLIRMN | 276 | O95259 | |
| GPQLKELNPEEGEMV | 1971 | O94854 | |
| TVPAEGAVKGLPEML | 6 | Q969G2 | |
| PGRLEVKMEIGLPDE | 386 | P46459 | |
| PMEPDEVLRKGSGTL | 486 | Q07864 | |
| RLTDAGIPPEVIMGI | 186 | Q5JSP0 | |
| IKIAPAEGPDVSERM | 461 | Q9Y6M1 | |
| RIPEEMPKGSVVGNL | 36 | Q9Y5G0 | |
| PVTMVLQGGPRIEEL | 1221 | Q9Y4D8 | |
| DPKPGVMTQEVGQLL | 1966 | Q7Z6Z7 | |
| VRMVIITGPPEAQFK | 451 | O00425 | |
| GLEKVPGIFISRMVP | 186 | Q9BYG4 | |
| VTKAGPMGLPEIRQV | 351 | Q9C0D0 | |
| GGTRDQLMPLPVKVS | 331 | Q9UII4 | |
| DRPVAIGGKVEVRPM | 401 | P36957 | |
| REAVVPIMAKAPQGV | 91 | Q9UMR5 | |
| VKGPGLQRMVLVDLP | 386 | O60313 | |
| KDLPAAGSEMQIRPI | 336 | Q9H1Y3 | |
| LQDVKGQEVPRPAMD | 421 | Q99572 | |
| MQRPPPGVKLVIEAV | 2941 | Q9P2D7 | |
| LMRKGQDSIEPVPGQ | 131 | Q9NR50 | |
| RKQGVQLPPAGMEEA | 2476 | Q4G0P3 | |
| ATPGNEIPVEVVLKM | 651 | P49915 | |
| PMELQVDVRVKPVGA | 121 | A4D1S0 | |
| PEEGMITVLGSDKVP | 141 | O15229 | |
| RKTGFPEIIMPGDVR | 411 | Q14185 | |
| VVARKLGFPEIIMPG | 406 | Q92608 | |
| TRKLGFPDVIMPGDI | 406 | Q8IZD9 | |
| RDVSPMGLKITGAIP | 256 | Q9UBN1 | |
| LTPVEEAPKGMLARG | 156 | P52566 | |
| GEVRMPSGKVAQPTI | 1806 | P21333 | |
| IGGVTERMPTPVIKA | 81 | P07954 | |
| SEPMPTGRVVGILQK | 326 | Q8TF46 | |
| NVPRDFEIKMPTLVG | 2251 | O75417 | |
| PNPRDLKIVVLMLTG | 2731 | P12111 | |
| GTKQEPMVRPGDRVA | 371 | Q9Y2E4 | |
| LPLMESGKILPGVRI | 1341 | Q9Y2E4 | |
| KVLPMLNPDGVIVGN | 496 | Q5U5Z8 | |
| PIGLSDIPGEAMVKL | 121 | P67870 | |
| MIEALGVLEPRGSPV | 981 | O75064 | |
| ELVGKPAFVMEPRQE | 156 | Q8N7U6 | |
| MVLPRKPVAGALDVS | 161 | Q99627 | |
| ILPEGKIMPNTVFVG | 31 | Q92904 | |
| MPVIPALGEAKGEVL | 1 | Q6ZN92 | |
| ENIPRGGTTMKEEPL | 6 | Q9H4W6 | |
| KGISEPIQAMQRPKG | 491 | Q9NW75 | |
| GPKRMLDAQVQTDPV | 561 | O75363 | |
| DLKPANILVMGEGPE | 151 | P49336 | |
| VAKPIPEELGMVQDV | 301 | O43405 | |
| QRPVEDGERGMKPTE | 316 | Q6NYC8 | |
| KLPMSIIIVGVGPAE | 461 | Q86YQ8 | |
| FGPEMTNPLREIDKI | 321 | Q13822 | |
| PIKPMQFLGDEETVR | 226 | P18669 | |
| DKLPAPGRAMVDIIL | 156 | Q96DY7 | |
| VIETPEGDKMPQLIV | 221 | Q9BZA8 | |
| GEVPRADLIVMLRGP | 76 | Q6S8J7 | |
| AGVEDIVAIMIPEPK | 161 | Q9ULK6 | |
| PQTVMEIDGLLGNKP | 386 | O43448 | |
| RKVMGQLQREASPGP | 206 | Q9GZY6 | |
| MEEIQLPPPRQGKEG | 2371 | P11717 | |
| IATENGAPMPLGKLI | 281 | Q8N4V2 | |
| GAPMPLGKLIISRQE | 286 | Q8N4V2 | |
| EKSRMGVVPPGTQVE | 51 | Q96NB2 | |
| KIEEIMPNGDPLLAG | 811 | P52630 | |
| GEVEMPLKGRRIGPI | 496 | Q9H7E2 | |
| LPGALAKPIMDQLVG | 56 | O15119 | |
| IPVVVLPTMEDKRGD | 1556 | Q9UPZ6 | |
| QPLEMKRVGVVFTPA | 681 | A2VDJ0 | |
| VGNPEESLEMPLRKQ | 3286 | Q8WXH0 | |
| MGTRDDVPEAKVLVP | 1 | Q6ZUX3 | |
| PNMKEDGILGPIIRA | 411 | P12259 | |
| LERNPIKMLPVELGS | 121 | Q9C0I9 | |
| RMNPEGDIKGVIPEL | 391 | A1A5C7 | |
| DVGSGGIRPKQPRML | 1751 | P21675 | |
| PNQGKMREIEEVLTP | 281 | P29622 | |
| MGTLPKRVKIVEVGP | 26 | P35914 | |
| ENVRIPGMLIIDTPG | 691 | O60841 | |
| IVPVGEALLENPKME | 276 | Q8N165 | |
| AMEKGLVPQNEGLPL | 1341 | P58107 | |
| NGTPAVPKMGVRARV | 66 | Q9P2F8 | |
| LDTRGSKGMELPPVQ | 426 | Q9ULL8 | |
| GVPIVLAMTRVVPDK | 596 | Q86UG4 | |
| DIPLKVVGMFPSRGE | 186 | Q9H5Q4 | |
| RGMVPIVLVAKLGPQ | 631 | O95785 | |
| NMLRGIGETPIVPLG | 131 | G3V0H7 | |
| PLMGNVDPSKIDEIR | 51 | Q8WXA9 | |
| PMEKEPGEGRISVVD | 391 | Q5SWA1 | |
| GDGIQILKDLPMNPR | 1586 | Q5VT25 | |
| NEKIAQRPGPMELVE | 71 | Q969V6 | |
| PMLTVDGKRVPRDAG | 301 | P14550 | |
| DLPVPAEGVRNIKSM | 701 | Q05682 | |
| LMGGAQTPTKQPEER | 566 | Q0VD83 | |
| LISPQAVGSGIPEMK | 181 | P35523 | |
| IPVIGKADALMPQET | 171 | Q8WYJ6 | |
| LAPGTLLGPKREVDM | 101 | Q9Y6X2 | |
| KQPPVGGVSDMRIKV | 381 | Q6S5L8 | |
| KGLMEIPANLPEGIV | 296 | O75094 | |
| VMPGKRRPNGVITGL | 91 | Q96QD9 | |
| VGPPMQELKDLGVTV | 151 | Q6PCB0 | |
| NGEPVQIRVPMGKEP | 471 | P09327 | |
| GIVMPVPEISQRIKA | 201 | Q96I15 | |
| VMSRKGPAPELQGVE | 811 | Q13435 | |
| LPMGSIKNVVSEPIE | 251 | O14562 | |
| SIMGIGPIPAIKQAV | 291 | Q9BWD1 | |
| PEKPREIGGRLLMVE | 1916 | O60673 | |
| PTVELNGLAMKRGEP | 96 | Q9NUL3 | |
| ITVVPMRGELEGKPI | 421 | Q9UQP3 | |
| MEGIRGDPEKRGVIP | 106 | O15066 | |
| PMVRLLEGEEVAGPL | 476 | Q9BRG2 | |
| PPMENKAEGTGVQLL | 281 | A7XYQ1 | |
| PKPRDSMLGDRGEII | 771 | O75038 | |
| SPNEMVGQKPLGEIT | 466 | Q6ZVD7 | |
| MKEIPVGLRLQTGTP | 61 | Q8N7X2 | |
| RPKLGGLMDPRQGVI | 51 | P24928 | |
| MLKRQPAIELPLGGE | 586 | Q5T1R4 | |
| VMTVQRGARPGVPKA | 621 | Q5GFL6 | |
| RTGKPLSVELGPGIM | 81 | P38606 | |
| KGIMADPTVNVPLLG | 111 | Q9Y5W5 | |
| KSVVMEGGEERPRLP | 291 | O43151 | |
| TGLIAPMKIRTEAPG | 581 | Q6PJI9 | |
| EKLPSVMAGVPARRG | 16 | O43379 | |
| LLGLPPGEEMELVTQ | 446 | O95049 | |
| EVFKIERPGEGSPMV | 276 | Q96T88 | |
| RINVKSEVMPGPIGL | 231 | Q9UJL9 | |
| MDGAPVKGESIPIRL | 236 | O75436 | |
| APGMKLEVAVRTDPE | 51 | Q9UHJ3 | |
| PLMVKVLDAVRGSPA | 31 | P02766 | |
| KPVITMEPLGLTEEG | 241 | P0DP72 | |
| EESLGGPMKVPILII | 316 | P31629 | |
| VRFIGPSPEVVRKMG | 136 | P11498 | |
| IPEKVTPMAAIQDGL | 226 | Q8WXD2 | |
| KEPPLGGVVDMRLRE | 356 | P29353 | |
| PEVPMGAERGKLDQL | 831 | Q562E7 | |
| VMNSEAKVLVPGIPG | 396 | Q15061 | |
| MTVGPPIAGLLRDKL | 431 | Q8TF71 | |
| DLKPRGVVVNMIPGL | 1381 | Q9NQX4 | |
| GIVMTLVPGRPKDVA | 76 | Q53FP2 | |
| MVGALPVDDPTLREK | 121 | Q9UHE5 | |
| QGIMNKEPAVIGRPD | 201 | O76041 |